The proposed training program is the centerpiece in efforts to provide postdoctoral training in laboratory genetics at Harvard Medical School. It has provided an opportunity to offer training to physicians and scientists in a wide variety of disciplines, enabling them to take advantage of the extraordinary rich environment offered at Harvard Medical School. It has also helped foster interactions between investigators, and provided a forum for increasing faculty contact with trainees in didactic sessions. The training units of the program include the HMS Department of Genetics, laboratories at Children's Hospital, Massachusetts General Hospital, Brigham and Women's Hospital, Dana Farber Cancer Institute, and Beth Israel Deaconess Medical Center. Although the focus of the training is on research the program is fully integrated with the Harvard Medical School Clinical Genetics Training Program. This program is accredited by the American Board of Medical Genetics in all areas of training (PhD Genetics, Cytogenetics, Biochemical Genetics, and Molecular Genetics) as well as by the American Council of Graduate Medical Education (MD Clinical Genetics). This provides an opportunity for trainees to become board eligible in a discipline of clinical genetics in addition to receive laboratory training. Fellowship training will be provided for two to three years. Support for ten postdoctoral trainees at level 4 or greater is requested.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
2T32GM007748-21
Application #
2721439
Study Section
Special Emphasis Panel (ZGM1-BRT-4 (01))
Project Start
1979-07-01
Project End
2004-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
21
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Harvard University
Department
Genetics
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Rohanizadegan, Mersedeh (2018) Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker. Cancer Genet 228-229:159-168
Demirbas, Didem; Brucker, William J; Berry, Gerard T (2018) Inborn Errors of Metabolism with Hepatopathy: Metabolism Defects of Galactose, Fructose, and Tyrosine. Pediatr Clin North Am 65:337-352
Schwartz, Talia S; Wojcik, Monica H; Pelletier, Renee C et al. (2018) Expanding the phenotypic spectrum associated with OPHN1 variants. Eur J Med Genet :
Zhu, Qihui; High, Frances A; Zhang, Chengsheng et al. (2018) Systematic analysis of copy number variation associated with congenital diaphragmatic hernia. Proc Natl Acad Sci U S A 115:5247-5252
Stachler, Matthew D; Camarda, Nicholas D; Deitrick, Christopher et al. (2018) Detection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma. Gastroenterology 155:156-167
Srivastava, Siddharth; Desai, Sonal; Cohen, Julie et al. (2018) Monogenic disorders that mimic the phenotype of Rett syndrome. Neurogenetics 19:41-47
Wojcik, Monica H; Brodsky, Dara; Stewart, Jane E et al. (2018) Peri-mortem evaluation of infants who die without a diagnosis: focus on advances in genomic technology. J Perinatol 38:1125-1134
Guissart, Claire; Latypova, Xenia; Rollier, Paul et al. (2018) Dual Molecular Effects of Dominant RORA Mutations Cause Two Variants of Syndromic Intellectual Disability with Either Autism or Cerebellar Ataxia. Am J Hum Genet 102:744-759
Takeda, David Y; Spisák, Sándor; Seo, Ji-Heui et al. (2018) A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer. Cell 174:422-432.e13
Rohanizadegan, Mersedeh; Sacharow, Stephanie (2018) Desmosterolosis presenting with multiple congenital anomalies. Eur J Med Genet 61:152-156

Showing the most recent 10 out of 113 publications